Sort
46,585 grants matching “heart failure”
Transition from Risk Factors to Early HF: Prevalence, Pathogenesis, and Phenomics
$1,319,272Alain Gerald Bertoni · Wake Forest University Health Sciences · R01 · FY2018 · HL
The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR)
$1,318,829Charles Chiedu Nwaokobia · Evon Medics, Llc · R44 · FY2023 · DA
CLINICAL EXAMINATION CENTER
$1,318,720Thomas H Mosley · University Of Mississippi Med Ctr · N01 · FY2016 · HL
Framingham Project/O'Donnell
$1,316,662Christopher O'Donnell · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
Induced Pluripotent Stem Cells in the Understanding and Treatment of Heart Diseas
$1,316,397Deepak Srivastava · J. David Gladstone Institutes · U01 · FY2015 · HL
Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging
$1,315,597Olga V Fedorova · National Institute On Aging · ZIA · FY2019 · AG
Human Pluripotent Stem Cell and Progenitor Models of Cardiac and Blood Diseases
$1,315,513Kenneth R Chien · Massachusetts General Hospital · U01 · FY2009 · HL
Cell Directed Immunomodulation Therapy as a Bridge to Left Ventricular Device Implantation in Chronic Heart Failure Patients
$1,314,026Kimberly Anne Johnston · Innovative Biotherapies, Inc. · R44 · FY2024 · HL
Equity and Climate Opportunities for Health (ECO-Health) Center: Research Project 1
$1,313,925Neeta Thakur · University Of California, San Francisco · P20 · FY2024 · MD
Improving Diagnostic Accuracy for Acute Heart Failure
$1,312,845Deepak Gupta · Vanderbilt University Medical Center · R01 · FY2023 · HL
Induced Pluripotent Stem Cells in the Understanding and Treatment of Heart Diseas
$1,312,613Deepak Srivastava · J. David Gladstone Institutes · U01 · FY2010 · HL
Oxidative Stress, AMPK &Diabetic Cardiovascular Disease
$1,312,516Boston Medical Center · P01 · FY2003 · HL
Cardiovascular Toxicity of Environmental Aldehydes
$1,312,348University Of Louisville · P01 · FY2003 · ES
BMT Survivor Study-2 (BMTSS-2)
$1,312,128Smita Bhatia · University Of Alabama At Birmingham · U01 · FY2019 · CA
Gene Therapy and Other Therapeutic Modalities in Treatment of Heart Failure
$1,309,417Mark Talan · Aging · Z01 · FY2007 · AG
Stopping Hydroxychloroquine In Elderly Lupus Disease (SHIELD)
$1,308,540Peter Izmirly · New York University School Of Medicine · R01 · FY2024 · AR
Remodeling potential of the mitral valve following surgical repair
$1,308,096Michael S Sacks · University Of Texas At Austin · R01 · FY2014 · HL
Optimizing Cardiovascular Device Thromboresistance for Eliminating Anticoagulants
$1,308,032Danny Bluestein · State University New York Stony Brook · U01 · FY2014 · EB
Remodeling potential of the mitral valve following surgical repair
$1,307,364Michael S Sacks · University Of Texas At Austin · R01 · FY2013 · HL
Chronic Kidney Disease in Children (CKiD)
$1,304,705Susan L Furth · Children'S Hosp Of Philadelphia · U01 · FY2024 · DK
Immunopathogenesis of Chronic Allograft Rejection
$1,303,933Children'S Hospital Boston · P01 · FY2004 · AI
Self Regulating Continuous Flow Total Artificial Heart
$1,303,828Kiyotaka Fukamachi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2013 · HL
Cardiac Biomarkers in Pediatric Cardiomyopathy
$1,302,791Robert D. Ross · Wayne State University · R01 · FY2016 · HL
Atherosclerosis Risk in Communities Study (ARIC)
$1,302,441Aaron R Folsom · University Of Minnesota · N01 · FY2010 · HL
Hereditary Muscle Disease Unit
$1,300,552Ami Mankodi · National Institute Of Neurological Disorders And Stroke · ZIA · FY2017 · NS